452 related articles for article (PubMed ID: 7731942)
1. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.
Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G
Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
8. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
9. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
Smaaland R; Lote K; Sothern RB; Laerum OD
Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the DNA content in low and high grade non-Hodgkin lymphomas.
Ruschenburg L; Misselwitz W; Korabiowska M; Droese M
Anticancer Res; 1998; 18(3A):1617-20. PubMed ID: 9673379
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
15. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
18. Comparative cytophotometric analysis of reactive lymphoid hyperplasia and low malignant non-Hodgkin lymphoma.
Ruschenburg I; Peters D; Korabiowska M; Droese M
Anticancer Res; 1998; 18(3A):1613-6. PubMed ID: 9673378
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]